Ownership history in JARISLOWSKY, FRASER Ltd · 56 quarters on record
This page tracks every 13F SEC filing in which JARISLOWSKY, FRASER Ltd reported a position in Abbott Laboratories Common (ABT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 2,158,089 | -37,740 | -1.7% | 1.59% | $289.1M | $132.67 |
| 2025 Q2 | ADDED | 2,195,829 | +26,112 | +1.2% | 1.71% | $298.7M | $134.12 |
| 2025 Q1 | REDUCED | 2,169,717 | -92,674 | -4.1% | 1.80% | $287.8M | $130.21 |
| 2024 Q4 | REDUCED | 2,262,391 | -114,939 | -4.8% | 1.49% | $254.0M | $110.45 |
| 2024 Q3 | ADDED | 2,377,330 | +172,772 | +7.8% | 1.52% | $271.0M | $110.80 |
| 2024 Q2 | ADDED | 2,204,558 | +124,685 | +6.0% | 1.39% | $229.1M | $100.45 |
| 2024 Q1 | REDUCED | 2,079,873 | -42,532 | -2.0% | 1.36% | $236.4M | $109.34 |
| 2023 Q4 | REDUCED | 2,122,405 | -58,487 | -2.7% | 1.37% | $233.6M | $105.38 |
| 2023 Q3 | REDUCED | 2,180,892 | -17,300 | -0.8% | 1.37% | $211.2M | $92.21 |
| 2023 Q2 | REDUCED | 2,198,192 | -59,999 | -2.7% | 1.43% | $239.6M | $103.30 |
As of 2025 Q4 — sorted by position size